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ABSTRACT  
Background: There exists a wide variation of the reported coeliac disease incidence in the 
last decades. We aimed to evaluate the incidence rate of coeliac diagnoses performed in an 
Italian region, Campania, between 2011 and 2013 and its variation therein.  
Methods: All coeliac diagnoses made from 2011 to 2013 and registered within the Campania 
CD register (CeliacDB) were identified. Incidence rates were analysed by sex, age and 
province of residence with a Poisson model fitted to determine incidence rate ratios.  
Results: We found 2,046 CD diagnoses registered in the CeliacDB between 2011 and 2013 
of whom 1,441 patients were females (70.4%) and 1,059 aged less than 19 years (51.7%). 
The overall incidence of coeliac disease in Campania was 11.8 per 100,000 person-years 
(95% CI 11.3-12.3) during the study period with marked variation by age [27.4 per 100,000 
person-years (95% CI 25.8-29.1) in children under 19 years of age and 7.3 per 100,000 (95% 
CI 6.8-7.8) in adults] and sex [16.1 per 100,000 person-years in females (95% CI 15.3-16.9) 
and 7.2 per 100,000 person-years in males (95% CI 6.6-7.8)]. Coeliac disease incidence was 
roughly similar in Naples, Salerno, Caserta and Avellino but about half in Benevento. More 
than 80% of our study population was diagnosed by the combination of positive 
antitransglutaminase IgA and Marsh 3. More than half of the patients were symptomatic at 
the time of the coeliac disease diagnosis (39.7% had a classical presentation and 21.1% a 
non-classical one according to the Oslo definition).  
Conclusions: Coeliac disease incidence was roughly similar among Campania provinces, 
except in Benevento where it was about half, probably due to less coeliac disease awareness 
in this area. The CD incidence in Campania appears lower than that reported by most of the 
previous literature, suggesting the necessity of new coeliac awareness programs. 
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INTRODUCTION  
Epidemiological studies have described a 2 to 6-fold increase in the incidence of coeliac 
disease (CD) in the population of Western countries (1)  in the last two decades, however,  
there exists a wide variation of the reported CD incidence since year 2000 possibly due to 
differences in the study populations and ascertainment of cases in these countries (2-11), yet 
the data from Italy are only from small studies. In Italy, coeliac patients need to receive a 
disease certificate from secondary outpatient clinics to benefit from a monthly amount of 
money to spend on gluten-free food. Therefore, patients diagnosed with CD are evaluated by 
at least one CD secondary centre which confirms the diagnosis and releases the disease 
certificate.  
Two Italian studies have reported the CD incidence in two small Italian provinces, retrieving 
the number of CD patients from two different sources. The first study was conducted in 
Brescia (10) and reported the data on newly diagnosed coeliac patients collected by the 
Celiac Disease Study Group (composed of gastroenterologists, paediatricians and 
pathologists working in the eight hospitals of the area), between 2000 and 2003. The authors 
found an incidence of CD of 17 per 100,000 person-years. Another study conducted in Terni 
(7), found an incidence of CD of 27.35 and 4.52 per 100,000 inhabitants in females and males 
respectively in 2010. However, because of the small sample size and small areas considered, 
these findings cannot be considered representative of the overall incidence of CD in Italy. In 
Campania the secondary CD centres have been asked to register every new patient (since 
2006) with a CD diagnosis in an online platform to generate the certificate (CeliaDB) (12).  
Therefore, through this platform it is possible to retrieve information on each patient at the 
time of CD diagnosis including date of diagnosis, region of diagnosis, demographics and 
mode of diagnosis.  
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The aim of the present study was to evaluate the incidence rate of CD diagnoses performed in 
Campania between 2011 and 2013, employing the data registered online by all the secondary 
regional CD centres looking at the differences in age, sex and province of residence.  
 
  
5 
 
MATERIAL AND METHODS 
Database (CeliaDB) 
In Campania, only two university medical centres located in Naples (one for children, the 
other one for adults) have been exclusively committed since the 1980s to the diagnosis and 
follow–up of CD. However, the increasing number of diagnoses in the last decades has 
required an increase in the number of specialized centres spread all over the region. The 
Campania Region Celiac Network was established in 2006, and the individuals responsible 
for the centres were trained to pursue the diagnosis of CD following shared protocols. 
Moreover, all secondary centres were progressively invited to register all previous CD 
diagnoses and each newly diagnosed person into CeliaDB. This database was created as part 
of an educational project on CD sponsored by the Regione Campania (12, 13). At the end of 
2010, 31 secondary centres were invited to take part to the project (16 in Naples, 7 in Salerno, 
4 in Caserta, 2 in Avellino and 2 in Benevento). All residents newly identified as affected 
with coeliac disease in the Campania region need a certificate from one of these centres to 
receive the monthly amount of money to spend on gluten-free food. Every participating 
centre was provided with a username and password to access the database. Demographic 
data, signs and symptoms at diagnosis and modes of diagnosis of each new coeliac patient are 
inserted into the database, after informed consent, by each centre at the moment of CD 
diagnosis to obtain the CD certificate. Data from this register have been recently used to 
participate to national multicentre studies of epidemiology on complication of CD (14-16).  
 
Study population 
All new coeliac diagnoses made from 2011 to 2013 and registered within the CeliaDB (17) in 
Campania were identified. Patients received a CD diagnosis and were included in the 
database if they had a duodenal biopsy showing intestinal damage, including lesions at least 
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of 1 according to Marsh classification (18), associated with positive anti-tissue 
transglutaminase/endomysial antibodies, or in the case of no biopsy, positive anti-tissue 
transglutaminase/endomysial antibodies and genetic predisposition (HLA testing), 
accompanied by a clinical reason why the biopsy was not performed. In the case of IgA 
deficiency, or in the case of seronegative CD, details on IgA total value, HLA testing and 
biopsy result had to be always reported in the database.  
Data on sex, age, signs and symptoms at diagnosis, how the CD diagnosis was performed 
(serology, histology, HLA), and province of residence were collected for each patient.  
Patients living outside Campania’s provinces at the time of diagnosis but who received their 
CD certificate in one of the Campania centre were excluded.  
The resident population in Campania was defined according to the Italian National Institute 
of Statistics (ISTAT) data (19). ISTAT’s activities include the census of the population, 
economic censuses and a number of social, economic and environmental surveys and 
analyses. ISTAT is by far the largest producer of Statistical information in Italy, and is an 
active member of the European Statistical System.  
 
Statistical analyses  
We calculated the incidence rate of CD by dividing the number of newly CD diagnosed cases 
by the time that people spent during the study period in each region (person-years) and 
estimated 95% Confidence Intervals (CI). The date of CD diagnosis was the date of the 
duodenal biopsy which confirmed the diagnosis or, when it was missing, the date of 
certificate release. We assumed that each resident in Campania in 2011- 2013 spent the whole 
year being “at risk,” so our denominator was estimated from the sum of the residents in 2011, 
2012 and 2013 respectively, according to ISTAT data. We stratified disease incidence by sex, 
age-group (categorised as 0-4, 5-19, 20-29, 30-49, 50-69 and 70 years and over, similarly to 
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those present in the ISTAT data), calendar year, and province of residence, (Naples, Salerno, 
Caserta, Avellino, Benevento).  Incidence rates were presented per 100,000 person-years with 
a Poisson model fitted to determine incidence rate ratios (IRR). These IRRs were fully 
adjusted for sex, age-group, calendar year (2011, 2012, 2013) and province of residence. We 
assessed the potential interaction between age and province of residence using the likelihood 
ratio test (LRT). The percentages of mode of CD diagnosis and the clinical presentation at the 
time of diagnosis were reported in each age-group. Missing data were always considered as a 
separated category.  
 
 
RESULTS 
Twenty-six CD centres actively used CeliacDB from 2011 and 2013 to get certification.  Five 
centres were considered to be inactive as they registered less than 10 patients in the period of 
study (2 in Naples, 1 in Salerno, 1 in Avellino and 1 in Benevento). In 2011 the total 
population of Campania was of 5,834,056 persons, in 2012 of 5,764,424 persons and of 
5,769,750 in 2013, with a percentage of females of 51.5% in each year. Therefore, the study 
had a total follow-up time of 17,368,230 person-years. According to ISTAT data, in 2013 
most people lived in Naples with a population of 3,055,339, followed by Salerno with 
1,093,453 inhabitants, Caserta with 908,784 inhabitants and Avellino and Benevento with 
428,523 and 283,651, respectively. The population distribution in the previous years was 
roughly similar. 
 
Overall incidence 
All patients with CD diagnosis gave their written informed consent to be included in the 
Campania registry. The Campania register listed 10,511 patients at the time of data extraction 
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(June 2014).  In 381 (3.6%) of them, the date of CD diagnosis was missing, and therefore 
excluded. In 2,049 (19.5%), the CD diagnoses were made between 2011 and 2013 and thus 
they were included in our study. Among these, 668 diagnoses occurred in 2011, 678 took 
place in 2012 and 703 in 2013. For the whole of Campania the incidence rate of CD was 11.8 
per 100,000 person-years (95% CI 11.3-12.3) and CD incidence was not statistically 
significantly different among the three years of analysis, even after adjusting for sex, age and 
province of residence (Table 1).  
 
Age and sex 
The rate of CD of 16.1 per 100,000 person-years was about 2.4 times higher in females than 
in males (IRR 2.39, 95% CI 2.18-2.64) after adjusting for year of diagnosis, age at diagnosis 
and province of residence. The highest incidence rate was found in people aged less than 4 
years, in whom the CD incidence was 53.4 per 100,000 person-years. CD incidence rate 
progressively decreased as the age increased (LRT p for trend <0.001), with the lowest CD 
incidence rate found in people aged more than 70 years, in whom the incidence rate was 98% 
lower than that in children aged less than 4 years (IRR 0.02, 95% CI 0.01-0.03). As Figure 1 
shows, the incidence rate of CD in females was higher than in males in each age group, with 
the highest difference between sexes in subjects aged 20-29, when the incidence of CD was 
3.52 higher in females than in males (IRR 3.52, 95% CI 2.71-4.57).   
Dividing our population into two age groups, i.e. those who got their CD diagnosis during the 
childhood (0-19 years) and ones during adulthood (>19 years), the incidence rate of CD was 
27.4 per 100,000 person-years (95% CI 25.8-29.1) in children and 7.3 per 100,000 person-
years (95% CI 6.8-7.8) in adults, corresponding to an CD incidence 73% lower in adults than 
in children (IRR 0.27, 95% CI 0.24-0.29). 
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As Table 1 shows, the highest CD incidence rate was found in Salerno, 14.3 per 100,000 
person-years, that was 32% higher compared to that found in Naples after adjusting for 
calendar period, sex and age at CD diagnosis (IRR 1.32, 95% CI 1.19-1.47). The lowest rate 
was reported in Benevento, 6.6 per 100,000 person-years, which was 46% lower than the 
incidence found in Naples after adjusting for calendar period, sex and age at CD diagnosis 
(IRR 0.64, 95% CI 0.49-0.84). CD incidence rates were similar in Naples, Caserta and 
Avellino. Age was not an effect modifier in the relationship between provinces and CD (LRT 
p interaction=0.1) as the age distribution was similar across the provinces (Table 2).  
 
Mode of diagnosis and clinical presentation at diagnosis 
Table 3 shows the mode of CD diagnosis according to the age groups. The diagnosis was 
based by the combination of positive antitransglutaminase IgA and Marsh 3 on histological 
evaluation of their small bowel in 1,732 subjects (84.6%); all the 83 patients with Marsh 1 
and the 63 with Marsh 2 on histological evaluation had positive serology, were HLA-DQ2 or 
DQ8 positive and were symptomatic.  Endoscopy was not performed in 146 people (7.1%) 
and in particular among people aged less than 4 and more than 70 years.  Among the 146 
patients who did not undergo endoscopy: 105 children were included into a validated long-
term trial for the ESPGHAN criteria, 5 women were pregnant at the time of CD diagnosis, 3 
children were affected by Down’s Syndrome, 2 had undergone skin biopsy and 20 cases 
refused the procedure (in the other subjects the reasons were: very old age and anti-coagulant 
therapy, respiratory diseases, severe neurological diseases). In 25 cases (1.2%) the diagnosis 
was made on patients with negative CD serology but positive histology (Marsh 3 lesion) and 
HLA-DQ2 positivity.  Among them, IgA deficiency was clearly reported in 6 subjects.   
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Restricting our main analysis to patients with positive antitransglutaminase IgA antibodies 
and Marsh 3 lesion on the histological evaluation (1,732), we found an incidence rate of CD 
of 10 per 100,000 person-years (95% CI 9.5-10.4).   
 
Table 4 summarizes the clinical presentation, following the Oslo criteria (20): 60.8% of our 
population reported at least one symptom at the time of CD diagnosis (classical and non-
classical symptoms), 7.5% were investigated for anaemia without any symptoms, while 13% 
where asymptomatic (no symptoms/no anaemia). In 18.7% of cases clinicians did not report 
patients’ clinical history in the register. Fifty-five (2.7%) had dermatitis herpetiformis at the 
time of CD diagnosis. Among them, 14 patients had no other signs or symptoms of CD.   
During the study period, two women received the CD diagnosis at the time of surgery for 
intestinal lymphoma and small bowel carcinoma, respectively. 
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DISCUSSION 
 
The overall incidence of CD in Campania was 11.8 per 100,000 person-years between 2011 
and 2013 with the highest incidence observed in females (16.1 per 100,000 person-years) 
compared to males and in children aged 0-4 years (53.4 per 100,000 person-years) compared 
to older patients. The incidence rate decreased as age increased similarly in each province of 
residence. CD incidence was roughly similar in Naples, Salerno, Caserta and Avellino (range: 
10.3-14.3 per 100,000) but about half in Benevento (6.6 per 100,000). More than 80% of our 
study population was diagnosed by the combination of positive serology and histology and 
more than half of the patients were symptomatic at the time of the CD diagnosis.  
 
 
Strengths and Limitations 
 
To the best of our knowledge, this is the first study which uses a regional register based on 
certification dedicated to CD where the secondary centres include all newly diagnosed 
coeliac patients with details on demographic aspects and mode of diagnosis across a region of 
the size of Campania, i.e. approximately 6 million inhabitants. Moreover, thanks to recent 
years analysed and the large sample size, our study provides both contemporary and 
reasonably precise estimates. Also, having all information on the mode of diagnosis, the risk 
of false positives occurring in our population is low.  
Some limitations of our study need to be considered. CeliaDB was instituted in 2006, but 
only at the end of 2010 were all secondary centres invited to use the database. Therefore, we 
were not able to present neither a trend of CD incidence over time nor an accurate prevalence 
of CD in Campania, since the CD diagnoses performed before 2010 were retrospectively 
included in the register only by few centres. Moreover, we cannot exclude an underestimation 
of our overall and age-sex specific incidence rates in the different provinces of Campania, 
possibly due to either a different use of the register and a different CD awareness between 
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paediatricians and gastroenterologists, or among the centres of the different provinces. We 
reported only 6,5% of diagnoses over the age of 50 years, which is lower compared to that 
reported from the  previous literature (11, 21). This may be related to the fact that clinical 
presentation in adults is more frequently characterised by non-classical presentation (20), 
often without any gastrointestinal symptoms (22) and therefore still  not recognised by GPs in 
our region, rather than a true difference in the incidence.  
Additionally, there is an unequal distribution of CD centres among the provinces with the 
highest number of centres in Naples and just one active adult centre in Avellino and 
Benevento and this could influence the number of people who are routinely tested for CD. 
Five centres were considered to be inactive as they registered less than 10 patients in the 
period of study; however we think we may only have lost a few patients because of these, 
since next to each of these five centres there is always a fully active celiac centre where 
patients can ask for consultation and get the CD certificate. Finally, in around 18% of our 
population, symptoms and signs at the time of diagnosis were missing and this could have 
compromised our findings on the clinical presentations; however we tried to avoid this bias, 
considering patients with missing data as an independent group.  
 
 
Comparison with previous reports 
The CD incidence estimates reported in the 2000s vary fairly widely among the available 
studies, probably due to differences in study populations and study designs.  A population-
based study from the UK (11), recently reported an overall CD incidence of 13.8 per 100,000 
person-years from 1990 to 2011, with a near fourfold increase in the incidence during the 
study period, reaching a rate of 19.14 per 100,000 person-years in 2011, that is higher than 
the overall incidence we found in 2011 (11.4 per 100,000 person-years). Similarly, a 
population-based study in Olmsted Country (2), Minnesota, reported an overall age- and sex-
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adjusted incidence of CD of 17.3 per 100,000 person-years in 2008-2010.  An even higher 
incidence rate was also reported in a study conducted on adults in Finland. Virta et al, (23)  
detected all coeliac patients aged more than 16 years, reporting an annual age-adjusted CD 
incidence of 39.3 per 100,000 people in 2004-2006 (5,020 new cases). Conversely, an 
American study (4), reported a lower incidence rate of CD in adults compared to our 
findings. The authors used the clinical data of all subjects who were active duty US military 
personnel serving between 1999 and 2008 (4). The authors reported a total of 455 cases of 
CD between 1999 and 2008, with an overall incidence of 3.55 per 100,000 person-years and 
in particular a CD incidence of 6.5 per 100,000 person-years in 2008. However, this study 
was not representative of the general population, since individuals with chronically ill health 
generally are not admitted into the military, and younger and older people were excluded. In 
children the highest CD was reported by a Swedish study (9) which, reported a CD incidence 
of 44 per 100,000 person-years in 2003 in subjects younger than 15. In particular, the authors 
found an incidence of 66 per 100,000 in children aged 0-1.9 years, 35 per 100,000 person-
years in children aged 2-4.9 year, and 23 per 100,000 person-years in children aged 5-14.9 
years old, during the whole period of evaluation (1998-2003). Conversely, others previous 
studies conducted on children reported a lower CD incidence rate compared to our findings 
(5, 6, 24).  Recently, Dixit et al (25) have confirmed a higher incidence of CD in females than 
in males, already known in the previous literature (26-28), but in particular the authors have 
described a lower proportion of newly diagnosed patients among young men (ages 18–29 
years) than in any other ages. Similarly, we reported the highest difference between sexes in 
subjects aged 20-29. 
 
Interpretation 
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The variation in CD incidence we have found among the five provinces of Campania is likely 
to be caused by patients and physician behaviour, and a different awareness of CD among 
provinces. For example, Benevento includes more rural areas compared to the other 
Campania provinces, so we can imagine that subjects tend to visit their doctors only in case 
of severe clinical conditions making it more difficult to capture subclinical and non-classic 
forms of CD. The different CD incidence rates between children and adults should stimulated 
new coeliac awareness programs based on teaching days and several local meetings with the 
general practitioners looking for adults. Finally, the gender disparity, in particular in young 
subjects, may be related to the evidence that women at this age often attend the doctor due to 
fertility related issues and moreover, those who are menstruating, are likely to show evidence 
of anaemia more commonly than men. 
 
CONCLUSION  
Our findings indicate that this condition is common among children in Italy and that there are 
likely to be opportunities to improve case finding and diagnosis for adults in areas outside 
large, urban, populations of which there are many in the South of Italy.  Our use of a 
prospectively collected web based coeliac database to describe this epidemiology indicates 
the potential value to researchers in the future who have an interest in the causes and 
consequences of CD. 
 
 
 
 
 
 
15 
 
Acknowledgements: The authors are grateful to the Assessorato Sanità of the Campania 
Region for continuous support to the Celiac network (progetto Malattie Rare). They are 
grateful also to Eliana Rispoli and Savio Pisa for their expertise in management of CeliaDB 
and the education provided to all participating centres.  
 
 
 
Potential Conflict of Interest: none 
Financial Disclosure: The authors have indicated they have no financial relationships relevant to this 
article to disclose. 
16 
 
REFERENCES 
 
1. Kang J, Kang A, Green A, et al. Systematic review: worldwide variation in the frequency of 
coeliac disease and changes over time. Aliment Pharmacol Ther 2013; 38: 226-245. 
2. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, et al. Increasing incidence of celiac disease in a 
north American population. Am J Gastroenterol 2013; 108: 818-824. 
3. White LE, Merrick VM, Bannerman E, et al. The Rising Incidence of Celiac Disease in Scotland. 
Pediatrics 2013; 132: e924-e931. 
4. Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US 
adult population. The American journal of gastroenterology 2012; 107: 1248-1255. 
5. Hurley JJ, Lee B, Turner JK, et al. Incidence and presentation of reported coeliac disease in 
Cardiff and the Vale of Glamorgan: the next 10 years. Eur J Gastroenterol Hepatol 2012; 24: 482-486. 
6. Dydensborg S, Toftedal P, Biaggi M, et al. Increasing prevalence of coeliac disease in 
Denmark: a linkage study combining national registries. Acta Paediatr 2012; 101: 179-184. 
7. Angeli G, Pasquini R, Panella V, et al. An epidemiologic survey of celiac disease in the Terni 
area (Umbria, Italy) in 2002-2010. J Prev Med Hyg 2012; 53: 20-23. 
8. Ress K, Luts K, Rägo T, et al. Nationwide study of childhood celiac disease incidence over a 
35-year period in Estonia. Eur J Pediatr 2012; 171: 1823-1828. 
9. Olsson C, Stenlund H, Hörnell A, et al. Regional variation in celiac disease risk within Sweden 
revealed by the nationwide prospective incidence register. Acta Paediatr 2009; 98: 337-342. 
10. Lanzini A, Lanzini A, Villanacci V, et al. Epidemiological, clinical and histopathologic 
characteristics of celiac disease: results of a case-finding population-based program in an Italian 
community. Scand J Gastroenterol 2005; 40: 950-957. 
11. West J, Fleming KM, Tata LJ, et al. Incidence and Prevalence of Celiac Disease and Dermatitis 
Herpetiformis in the UK Over Two Decades: Population-Based Study. The American journal of 
gastroenterology 2014; 109: 757-768. 
12. Ciacci C, De Florio M. Evaluation of an instrument for the surveillance of adult gluten 
intolerance diagnosis: Report of the first year of activity of the Campania Celiac Network for Adult 
Celiac Disease. Digestive and Liver Disease 2007; 39: 703-704. 
13. Regione Campania. Available from: www.regione.campania.it. 
14. Biagi F, Schiepatti A, Malamut G, et al. PROgnosticating COeliac patieNts SUrvivaL: The 
PROCONSUL Score. PloS one 2014; 9: e84163. 
15. Biagi F, Marchese A, Ferretti F, et al. A multicentre case control study on complicated coeliac 
disease: two different patterns of natural history, two different prognoses. BMC gastroenterology 
2014; 14: 139. 
16. Biagi F, Gobbi P, Marchese A, et al. Low incidence but poor prognosis of complicated coeliac 
disease: a retrospective multicentre study. Digestive and Liver Disease 2014; 46: 227-230. 
17. Celiac DB - Registro Regionale per lo studio della malattia celiaca. Available from: 
www.registrocampaniaceliachia.org. 
18. Marsh M. Gluten, major histocompatibility complex, and the small intestine. A molecular 
and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 
1992; 102: 330-350. 
19. The National Institute for Statistics (ISTAT). Available from: www.istat.it/en/‎. 
20. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related 
terms. Gut 2013; 62: 43-52. 
21. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of 
celiac disease in elderly people: a population-based study. BMC gastroenterology 2009; 9: 49. 
22. Tursi A, Giorgetti G, Brandimarte G, et al. Prevalence and clinical presentation of 
subclinical/silent celiac disease in adults: an analysis on a 12-year observation. 
Hepatogastroenterology 2000; 48: 462-464. 
17 
 
23. Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in 
Finland: results of effective case finding in adults. Scand J Gastroenterol 2009; 44: 933-938. 
24. White LE, Bannerman E, McGrogan P, et al. Childhood coeliac disease diagnoses in Scotland 
2009–2010: the SPSU project. Arch Dis Child 2013; 98: 52-56. 
25. Dixit R, Lebwohl B, Ludvigsson JF, et al. Celiac Disease Is Diagnosed Less Frequently in Young 
Adult Males. Dig Dis Sci 2014: 1-4. 
26. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the 
USA: results of a national survey. Am J Gastroenterol 2001; 96: 126-131. 
27. Ciacci C, Cirillo M, Sollazzo R, et al. Gender and clinical presentation in adult celiac disease. 
Scand J Gastroenterol 1995; 30: 1077-1081. 
28. Murray JA, Dyke CV, Plevak MF, et al. Trends in the identification and clinical features of 
celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 2003; 1: 19-
27. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
Figure 1: Incidence rates of CD per 100,000 person-years according to age-group in females 
and males.  
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Table 1. Incidence rate of coeliac disease in Campania by province of residence, sex, age at 
diagnosis and year of diagnosis during the period 2011-2013 
 
 Cases Person-
years
a
 
CD Incidence 
per 100,000 
person-years 
(95% CI) 
Crude IRR 
(95% CI) 
Adjusted IRR
b
 
(95% CI) 
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 aISTAT data 2011 and 2012 and 2013 
badjusted for all other variables in the table 
 
 
 
 
 
  
All 2049 17,368,230 11.8 (11.3-12.3)   
Years      
      2011 668 5,834,056 11.4 (10.6-12.3) 1 1 
      2012 678 5,764,424 11.8 (10.9-12.7) 1.03 (0.92-1.14) 1.04 (0.93-1.16) 
      2013 703 5,769,750 12.2 (11.3-13.1) 1.06 (0.95-1.18) 1.09 (0.98-1.21) 
Sex      
     Male 608 8,420,803 7.2 (6.6-7.8) 1 1 
     Female 1,441 8,947,427 16.1 (15.3-16.9) 2.23 (2.02-2.45) 2.39 (2.18-2.63) 
Age sub-groups      
    <4 467 874,461 53.4 (48.7-58.5) 1 1 
    5-19 592 2,989,882 19.8 (18.2-21.5) 0.37 (0.33-0.42) 0.37 (0.32-0.42) 
   20-29 325 2,278,981 14.2 (12.7-15.9) 0.27 (0.23-0.31) 0.26 (0.23-0.31) 
   30-49 532 5,145,380 10.3 (9.5-11.2) 0.19 (0.17-0.22) 0.19 (0.16-0.21) 
   50-69 111 3,999,399 2.8 (2.3-3.3) 0.05 (0.04-0.06) 0.05 (0.04-0.06) 
   70+ 22 2,080,127 1.1 (0.6-1.6) 0.02 (0.01-0.03) 0.02 (0.01-0.03) 
Province of 
residence 
     
   Naples 1,082 9,189,459 11.8 (11.1-12.5) 1 1 
  Salerno 473 3,295,732 14.3 (13.1-15.7) 1.22 (1.09-1.35) 1.32 (1.19-1.47) 
  Caserta 281 2,730,439 10.3 (9.1-11.6) 0.87 (0.76-0.99) 0.87 (0.77-1.0) 
  Avellino 156 1,296,515 12.0 (10.2-14.1) 1.02 (0.86-1.21) 1.15 (0.97-1.36) 
  Benevento 57 856,085 6.6 (5.0-8.6) 0.56 (0.43-0.73) 0.64 (0.49-0.84) 
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Table 2.Incidence rate of coeliac disease in Campania by age at diagnosis in each province of 
residence during the period 2011-2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aISTAT data 2011 and 2012 and 2013 
NA: Naples; SA Salerno; CE Caserta; AV Benevento; BN Benevento 
  
  Cases Person-years
a
 CD Incidence per 
100,000 person-years 
(95% CI) 
NA Age-groups    
   <4 271 492,272 55 (48.7-62) 
    5-19 331 1,666,055 19.9 (17.8-22.1) 
   20-29 162 1,220,185 13.3 (11.3-15.5) 
   30-49 256 2,724,817 9.4 (8.3-10.6) 
   50-69 51 2,101,400 2.4 (1.8-3.2) 
   70+ 11 984,730 1.1 (0.6-2) 
SA Age-groups    
   <4 101 149,464 67.6 (55-82.1) 
    5-19 129 517,908 24.9 (20.8-29.9) 
   20-29 69 422,656 16.3 (12.7-20.7) 
   30-49 131 967,082 13.5 (11.3-16.1) 
   50-69 34 782,476 4.3 (3-6.1) 
   70+ 9 456,146 2 (0.9-3.7) 
CE Age-groups    
   <4 54 143,526 37.6 (28.2-49.1) 
    5-19 74 482,964 15.3 (12.0-19.2) 
   20-29 53 366,374 14.5 (10.8-18.9) 
   30-49 86 830,747 10.3 (8.2-12.8) 
   50-69 13 607,149 2.1 (1.1-3.6) 
   70+ 1 299,679 0.3 (0.008-1.8) 
AV Age-groups    
    <4 24 53,986 44.4 (28.5-66.1) 
    5-19 44 194,527 22.6 (16.4-30.3) 
    20-29 33 163,487 20.2 (13.9-28.3) 
    30-49 42 378,442 11.1 (8.0-15.0) 
    50-69 12 306,644 3.9 (2.0-6.8) 
    70+ 1 199,429 0.5 (0.01-2.7) 
BN Age-groups    
    <4 17 35,213 48.3 (28.1-77.3) 
    5-19 14 128,428 10.9 (5.9-18.3) 
   20-29 8 106,279 7.5 (3.2-14.8) 
   30-49 17 244,292 6.9 (4.0-11.1) 
   50-69 1 201,730 0.5 (0.01-2.7) 
   70+ 0 140,143 0 
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Table 3. Modes of CD diagnosis in Campania register according to the age groups  
 
Ab: antitransglutaminase and antiendomysial antibodies 
 
  
 Only 
Marsh 3 
(%) 
Ab + Marsh 1 
(%) 
Ab + 
Marsh 2 
(%) 
Ab + Marsh 3 
(%) 
Ab + HLA + 
Symptoms (%) 
All ages 25 (1.2) 83 (4) 63 (3.1) 1,732 (84.6) 146 (7.1) 
Age groups      
<4 0 16 (3.4) 6 (1.3) 358 (76.7) 87 (18.6) 
5-19 2 (0.3) 30 (5.1) 12 (2) 508 (85.8) 40 (6.8) 
20-29 10( 3.1) 12 (3.7) 11 (3.4) 288 (88.6) 4 (1.2) 
30-49 7 (1.3) 21 (3.9) 27 (5.1) 468 (88) 9 (1.7) 
50-69 5 (4.5) 3 (2.7) 4 (3.6) 97 (87.4) 2 (1.8) 
70+ 1 (4.6) 1 (4.6) 3 (13.6) 13 (59) 4 (18.2) 
23 
 
Table 4. Modes of CD clinical presentation 
Clinical 
presentation 
Classical 
presentation 
(malabsorption 
symptoms
a
) (%) 
Non-classical 
presentation 
(other 
symptoms
b
) 
(%) 
Non-classical 
presentation 
(only 
anaemia) 
(%) 
Asymptomatic 
(%) 
Missing 
(%) 
All age 813 (39.7) 433 (21.1) 154 (7.5) 266 (13) 383 (18.7) 
<4 207 (44.3) 68 (14.7) 25 (5.3) 44 (9.4) 123 (26.3) 
5-19 174 (29.4) 123 (20.8) 43 (7.3) 114 (19.2) 138 (23.3) 
All children 381 (36) 191 (18) 68 (6.4) 158 (15) 261 (24.6) 
20-29 148 (45.5) 82 (25.2) 22 (6.8) 37 (11.4) 36 (11.1) 
30-49 217 (40.7) 138 (25.9) 52 (10) 63 (11.8) 62 (11.6) 
50-69 55 (49.6) 20 (18) 9 (8.1) 6 (5.4) 21 (18.9) 
70+ 12 (54.6) 2 (9.1) 3 (13.6) 2 (9.1) 3 (13.6) 
All adults 432 (43.6) 242 (24.5) 86 (8.7) 108 (10.9)  122 (12.3) 
aAt least one among: diarrhoea, weight loss, failure to thrive  
b At least one among: lack of appetite, vomit, meteorism, abdominal pain, constipation, asthenia, dyspepsia 
 
 
 
